Angiodynamics (ANGO) Current Deferred Revenue (2012 - 2014)

Angiodynamics (ANGO) has 3 years of Current Deferred Revenue data on file, last reported at $1.5 million in Q1 2014.

• For the quarter ending Q1 2014, Current Deferred Revenue fell 60.19% year-over-year to $1.5 million; the trailing twelve-month figure through Feb 2014 stood at $1.5 million (down 60.19% YoY), and the FY2013 full-year result was $1.6 million, down 49.87% from the prior year.
• Current Deferred Revenue for Q1 2014 stood at $1.5 million, down from $1.6 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $3.7 million in Q1 2013 and bottomed at $1.5 million in Q1 2014.
• The 3-year median for Current Deferred Revenue is $2.3 million (2012), against an average of $2.4 million.
• The widest annual swing landed in 2013, when Current Deferred Revenue sank 45.35%; it then tumbled 60.19% in 2014.
• A 3-year view of Current Deferred Revenue shows it stood at $3.0 million in 2012, then tumbled by 45.35% to $1.6 million in 2013, then fell by 8.97% to $1.5 million in 2014.
• The last three Current Deferred Revenue figures came in at $1.5 million (Q1 2014), $1.6 million (Q4 2013), and $1.6 million (Q3 2013), per Business Quant data.

Peer Comparison